APO Research
Talk to an analyst

APO RESEARCH · REPORT

Sphingosine 1-Phosphate Receptor 1

Sphingosine-1-phosphate receptor 1 (S1P receptor 1 or S1P1), also known as endothelial differentiation gene 1 (EDG1) is a protein that in humans is encoded by the S1PR1 gene. S1PR1 is a G-protein-coupled receptor which binds the bioactive signaling molecule sphingosine 1-phosphate (S1P). S1PR1 belongs to a sphingosine-1-phosphate receptor subfamily comprising five members (S1PR1-5). S1PR1 was originally identified as an abundant transcript in endothelial cells and it has an important role in regulating endothelial cell cytoskeletal structure, migration, capillary-like network formation and vascular maturation. In addition, S1PR1 signaling is important in the regulation of lymphocyte maturation, migration and trafficking.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Sphingosine-1-phosphate receptor 1 (S1P receptor 1 or S1P1), also known as endothelial differentiation gene 1 (EDG1) is a protein that in humans is encoded by the S1PR1 gene. S1PR1 is a G-protein-coupled receptor which binds the bioactive signaling molecule sphingosine 1-phosphate (S1P). S1PR1 belongs to a sphingosine-1-phosphate receptor subfamily comprising five members (S1PR1-5). S1PR1 was originally identified as an abundant transcript in endothelial cells and it has an important role in regulating endothelial cell cytoskeletal structure, migration, capillary-like network formation and vascular maturation. In addition, S1PR1 signaling is important in the regulation of lymphocyte maturation, migration and trafficking.

Selected research

Market Outlook & Growth Opportunities

Global Sphingosine 1-Phosphate Receptor 1 Market Outlook and Growth Opportunities 2026

30 December 2025191 pages

Choose your research edition.

Industry ResearchSphingosine 1-Phosphate Receptor 1 Industry Research Report 2026112 pages · $2,950 USDIndustry Growth & TrendsGlobal Sphingosine 1-Phosphate Receptor 1 Industry Growth and Trends Forecast to 203278 pages · $3,450 USDMarket StructureGlobal Sphingosine 1-Phosphate Receptor 1 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032174 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Sphingosine 1-Phosphate Receptor 1 Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Sphingosine 1-Phosphate Receptor 1 Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

Sphingosine-1-phosphate receptor 1 (S1P receptor 1 or S1P1), also known as endothelial differentiation gene 1 (EDG1) is a protein that in humans is encoded by the S1PR1 gene. S1PR1 is a G-protein-coupled receptor which binds the bioactive signaling molecule sphingosine 1-phosphate (S1P). S1PR1 belongs to a sphingosine-1-phosphate receptor subfamily comprising five members (S1PR1-5). S1PR1 was originally identified as an abundant transcript in endothelial cells and it has an important role in regulating endothelial cell cytoskeletal structure, migration, capillary-like network formation and vascular maturation. In addition, S1PR1 signaling is important in the regulation of lymphocyte maturation, migration and trafficking.

In the last several years, global market of Sphingosine 1-Phosphate Receptor 1 developed rapidly, with an average growth rate of 3.5%, Sphingosine 1-Phosphate Receptor 1 is widely used in Hospital, Clinic. North America is the largest consumption place, with a revenue market share nearly 57.1% in 2019,. and market competition is not intense.

This report provides an overview of the global Sphingosine 1-Phosphate Receptor 1 market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Sphingosine 1-Phosphate Receptor 1 and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Sphingosine 1-Phosphate Receptor 1 sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Sphingosine 1-Phosphate Receptor 1 market size, projected growth trends, production technologies, key applications, and end-use industries.

Sphingosine 1-Phosphate Receptor 1 Segment by Company

Novartis AG

Bristol-Myers Squibb Company

Sphingosine 1-Phosphate Receptor 1 Segment by Type

Fingolimod

Siponimod

Ozanimod

Other

Sphingosine 1-Phosphate Receptor 1 Segment by Application

Hospital

Clinic

Other

Sphingosine 1-Phosphate Receptor 1 Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Sphingosine 1-Phosphate Receptor 1 status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Sphingosine 1-Phosphate Receptor 1 market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Sphingosine 1-Phosphate Receptor 1 significant trends, drivers, influence factors in global and regions.

6. To analyze Sphingosine 1-Phosphate Receptor 1 competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sphingosine 1-Phosphate Receptor 1 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Sphingosine 1-Phosphate Receptor 1 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sphingosine 1-Phosphate Receptor 1.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Sphingosine 1-Phosphate Receptor 1 market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Sphingosine 1-Phosphate Receptor 1 industry.

Chapter 3: Detailed analysis of Sphingosine 1-Phosphate Receptor 1 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Sphingosine 1-Phosphate Receptor 1 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Sphingosine 1-Phosphate Receptor 1 in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Sphingosine 1-Phosphate Receptor 1 Industry Trends Table 2. Sphingosine 1-Phosphate Receptor 1 Industry Drivers Table 3. Sphingosine 1-Phosphate Receptor 1 Industry Opportunities and Challenges Table 4. Sphingosine 1-Phosphate Receptor 1 Industry Restraints Table 5. Global Sphingosine 1-Phosphate Receptor 1 Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Sphingosine 1-Phosphate Receptor 1 Revenue Share by Company (2021-2026) Table 7. Global Sphingosine 1-Phosphate Receptor 1 Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Sphingosine 1-Phosphate Receptor 1 Sales Volume Share by Company (2021-2026) Table 9. Global Sphingosine 1-Phosphate Receptor 1 Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Sphingosine 1-Phosphate Receptor 1 Company Ranking, (2024-2026) & (USD Million) Table 11. Global Sphingosine 1-Phosphate Receptor 1 Key Company Manufacturing Base & Headquarters Table 12. Global Sphingosine 1-Phosphate Receptor 1 Company, Product Type & Application Table 13. Global Sphingosine 1-Phosphate Receptor 1 Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Sphingosine 1-Phosphate Receptor 1 by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Fingolimod Table 18. Significant Companies of Siponimod Table 19. Significant Companies of Ozanimod Table 20. Significant Companies of Other Table 21. Global Sphingosine 1-Phosphate Receptor 1 Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global Sphingosine 1-Phosphate Receptor 1 Sales Volume by Type (2021-2026) & (K Units) Table 23. Global Sphingosine 1-Phosphate Receptor 1 Sales Volume by Type (2027-2032) & (K Units) Table 24. Global Sphingosine 1-Phosphate Receptor 1 Sales Volume Share by Type (2021-2026) Table 25. Global Sphingosine 1-Phosphate Receptor 1 Sales Volume Share by Type (2027-2032) Table 26. Global Sphingosine 1-Phosphate Receptor 1 Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Sphingosine 1-Phosphate Receptor 1 Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Sphingosine 1-Phosphate Receptor 1 Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Type (2021-2026) Table 30. Global Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Hospital Table 32. Significant Companies of Clinic Table 33. Significant Companies of Other Table 34. Global Sphingosine 1-Phosphate Receptor 1 Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global Sphingosine 1-Phosphate Receptor 1 Sales Volume by Application (2021-2026) & (K Units) Table 36. Global Sphingosine 1-Phosphate Receptor 1 Sales Volume by Application (2027-2032) & (K Units) Table 37. Global Sphingosine 1-Phosphate Receptor 1 Sales Volume Share by Application (2021-2026) Table 38. Global Sphingosine 1-Phosphate Receptor 1 Sales Volume Share by Application (2027-2032) Table 39. Global Sphingosine 1-Phosphate Receptor 1 Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Sphingosine 1-Phosphate Receptor 1 Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Sphingosine 1-Phosphate Receptor 1 Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Application (2021-2026) Table 43. Global Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Application (2027-2032) Table 44. Global Sphingosine 1-Phosphate Receptor 1 Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global Sphingosine 1-Phosphate Receptor 1 Sales by Region (2021-2026) & (K Units) Table 46. Global Sphingosine 1-Phosphate Receptor 1 Sales Market Share by Region (2021-2026) Table 47. Global Sphingosine 1-Phosphate Receptor 1 Sales by Region (2027-2032) & (K Units) Table 48. Global Sphingosine 1-Phosphate Receptor 1 Sales Market Share by Region (2027-2032) Table 49. Global Sphingosine 1-Phosphate Receptor 1 Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Sphingosine 1-Phosphate Receptor 1 Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Region (2021-2026) Table 52. Global Sphingosine 1-Phosphate Receptor 1 Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Region (2027-2032) Table 54. Global Sphingosine 1-Phosphate Receptor 1 Market Average Price (US$/Unit) by Region (2021-2026) Table 55. Global Sphingosine 1-Phosphate Receptor 1 Market Average Price (US$/Unit) by Region (2027-2032) Table 56. Global Sphingosine 1-Phosphate Receptor 1 Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. Global Sphingosine 1-Phosphate Receptor 1 Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Sphingosine 1-Phosphate Receptor 1 Sales by Country (2021-2026) & (K Units) Table 59. Global Sphingosine 1-Phosphate Receptor 1 Sales Market Share by Country (2021-2026) Table 60. Global Sphingosine 1-Phosphate Receptor 1 Sales by Country (2027-2032) & (K Units) Table 61. Global Sphingosine 1-Phosphate Receptor 1 Sales Market Share by Country (2027-2032) Table 62. Global Sphingosine 1-Phosphate Receptor 1 Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Sphingosine 1-Phosphate Receptor 1 Sales Value Market Share by Country (2021-2026) Table 64. Global Sphingosine 1-Phosphate Receptor 1 Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Sphingosine 1-Phosphate Receptor 1 Sales Value Market Share by Country (2027-2032) Table 66. Novartis AG Company Information Table 67. Novartis AG Business Overview Table 68. Novartis AG Sphingosine 1-Phosphate Receptor 1 Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Novartis AG Sphingosine 1-Phosphate Receptor 1 Product Portfolio Table 70. Novartis AG Recent Development Table 71. Bristol-Myers Squibb Company Company Information Table 72. Bristol-Myers Squibb Company Business Overview Table 73. Bristol-Myers Squibb Company Sphingosine 1-Phosphate Receptor 1 Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Bristol-Myers Squibb Company Sphingosine 1-Phosphate Receptor 1 Product Portfolio Table 75. Bristol-Myers Squibb Company Recent Development Table 76. Key Raw Materials Table 77. Raw Materials Key Suppliers Table 78. Sphingosine 1-Phosphate Receptor 1 Distributors List Table 79. Sphingosine 1-Phosphate Receptor 1 Customers List Table 80. Research Programs/Design for This Report Table 81. Authors List of This Report Table 82. Secondary Sources Table 83. Primary Sources List of Figures Figure 1. Sphingosine 1-Phosphate Receptor 1 Product Image Figure 2. Global Sphingosine 1-Phosphate Receptor 1 Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Sphingosine 1-Phosphate Receptor 1 Sales Value (2021-2032) & (US$ Million) Figure 4. Global Sphingosine 1-Phosphate Receptor 1 Sales (2021-2032) & (K Units) Figure 5. Global Sphingosine 1-Phosphate Receptor 1 Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Sphingosine 1-Phosphate Receptor 1 Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Fingolimod Image Figure 10. Siponimod Image Figure 11. Ozanimod Image Figure 12. Other Image Figure 13. Global Sphingosine 1-Phosphate Receptor 1 Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Sphingosine 1-Phosphate Receptor 1 Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Sphingosine 1-Phosphate Receptor 1 Sales Volume Share by Type (2021-2032) Figure 16. Global Sphingosine 1-Phosphate Receptor 1 Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Sphingosine 1-Phosphate Receptor 1 Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Type (2021-2032) Figure 19. Hospital Image Figure 20. Clinic Image Figure 21. Other Image Figure 22. Global Sphingosine 1-Phosphate Receptor 1 Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Sphingosine 1-Phosphate Receptor 1 Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Sphingosine 1-Phosphate Receptor 1 Sales Volume Share by Application (2021-2032) Figure 25. Global Sphingosine 1-Phosphate Receptor 1 Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Sphingosine 1-Phosphate Receptor 1 Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Application (2021-2032) Figure 28. Global Sphingosine 1-Phosphate Receptor 1 Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 29. Global Sphingosine 1-Phosphate Receptor 1 Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Sphingosine 1-Phosphate Receptor 1 Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Sphingosine 1-Phosphate Receptor 1 Sales Value (2021-2032) & (US$ Million) Figure 33. North America Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Sphingosine 1-Phosphate Receptor 1 Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Sphingosine 1-Phosphate Receptor 1 Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Sphingosine 1-Phosphate Receptor 1 Sales Value (2021-2032) & (US$ Million) Figure 39. South America Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Sphingosine 1-Phosphate Receptor 1 Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Sphingosine 1-Phosphate Receptor 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Sphingosine 1-Phosphate Receptor 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Sphingosine 1-Phosphate Receptor 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Sphingosine 1-Phosphate Receptor 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Sphingosine 1-Phosphate Receptor 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Sphingosine 1-Phosphate Receptor 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Sphingosine 1-Phosphate Receptor 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Sphingosine 1-Phosphate Receptor 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Sphingosine 1-Phosphate Receptor 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Sphingosine 1-Phosphate Receptor 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Sphingosine 1-Phosphate Receptor 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Sphingosine 1-Phosphate Receptor 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Sphingosine 1-Phosphate Receptor 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Sphingosine 1-Phosphate Receptor 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Sphingosine 1-Phosphate Receptor 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Sphingosine 1-Phosphate Receptor 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Sphingosine 1-Phosphate Receptor 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Sphingosine 1-Phosphate Receptor 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Sphingosine 1-Phosphate Receptor 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Sphingosine 1-Phosphate Receptor 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Sphingosine 1-Phosphate Receptor 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Sphingosine 1-Phosphate Receptor 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Sphingosine 1-Phosphate Receptor 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Sphingosine 1-Phosphate Receptor 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Sphingosine 1-Phosphate Receptor 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Sphingosine 1-Phosphate Receptor 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Sphingosine 1-Phosphate Receptor 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Sphingosine 1-Phosphate Receptor 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Sphingosine 1-Phosphate Receptor 1 Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Sphingosine 1-Phosphate Receptor 1 Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Fingolimod
  • Siponimod
  • Ozanimod
  • Other
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Novartis AG
  • Bristol-Myers Squibb Company

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Sphingosine 1-Phosphate Receptor 1 Sales Value (2021-2032)
  4. 1.2.2 Global Sphingosine 1-Phosphate Receptor 1 Sales Volume (2021-2032)
  5. 1.2.3 Global Sphingosine 1-Phosphate Receptor 1 Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Sphingosine 1-Phosphate Receptor 1 Market Dynamics
  1. 2.1 Sphingosine 1-Phosphate Receptor 1 Industry Trends
  2. 2.2 Sphingosine 1-Phosphate Receptor 1 Industry Drivers
  3. 2.3 Sphingosine 1-Phosphate Receptor 1 Industry Opportunities and Challenges
  4. 2.4 Sphingosine 1-Phosphate Receptor 1 Industry Restraints
3 Sphingosine 1-Phosphate Receptor 1 Market by Company
  1. 3.1 Global Sphingosine 1-Phosphate Receptor 1 Company Revenue Ranking in 2025
  2. 3.2 Global Sphingosine 1-Phosphate Receptor 1 Revenue by Company (2021-2026)
  3. 3.3 Global Sphingosine 1-Phosphate Receptor 1 Sales Volume by Company (2021-2026)
  4. 3.4 Global Sphingosine 1-Phosphate Receptor 1 Average Price by Company (2021-2026)
  5. 3.5 Global Sphingosine 1-Phosphate Receptor 1 Company Ranking (2024-2026)
  6. 3.6 Global Sphingosine 1-Phosphate Receptor 1 Company Manufacturing Base and Headquarters
  7. 3.7 Global Sphingosine 1-Phosphate Receptor 1 Company Product Type and Application
  8. 3.8 Global Sphingosine 1-Phosphate Receptor 1 Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Sphingosine 1-Phosphate Receptor 1 Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Sphingosine 1-Phosphate Receptor 1 Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Sphingosine 1-Phosphate Receptor 1 Market by Type
  1. 4.1 Sphingosine 1-Phosphate Receptor 1 Type Introduction
  2. 4.1.1 Fingolimod
  3. 4.1.2 Siponimod
  4. 4.1.3 Ozanimod
  5. 4.1.4 Other
  6. 4.2 Global Sphingosine 1-Phosphate Receptor 1 Sales Volume by Type
  7. 4.2.1 Global Sphingosine 1-Phosphate Receptor 1 Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Sphingosine 1-Phosphate Receptor 1 Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Sphingosine 1-Phosphate Receptor 1 Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Sphingosine 1-Phosphate Receptor 1 Sales Value by Type
  11. 4.3.1 Global Sphingosine 1-Phosphate Receptor 1 Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Sphingosine 1-Phosphate Receptor 1 Sales Value by Type (2021-2032)
  13. 4.3.3 Global Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Type (2021-2032)
5 Sphingosine 1-Phosphate Receptor 1 Market by Application
  1. 5.1 Sphingosine 1-Phosphate Receptor 1 Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Sphingosine 1-Phosphate Receptor 1 Sales Volume by Application
  6. 5.2.1 Global Sphingosine 1-Phosphate Receptor 1 Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Sphingosine 1-Phosphate Receptor 1 Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Sphingosine 1-Phosphate Receptor 1 Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Sphingosine 1-Phosphate Receptor 1 Sales Value by Application
  10. 5.3.1 Global Sphingosine 1-Phosphate Receptor 1 Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Sphingosine 1-Phosphate Receptor 1 Sales Value by Application (2021-2032)
  12. 5.3.3 Global Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Application (2021-2032)
6 Sphingosine 1-Phosphate Receptor 1 Regional Sales and Value Analysis
  1. 6.1 Global Sphingosine 1-Phosphate Receptor 1 Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Sphingosine 1-Phosphate Receptor 1 Sales by Region (2021-2032)
  3. 6.2.1 Global Sphingosine 1-Phosphate Receptor 1 Sales by Region: 2021-2026
  4. 6.2.2 Global Sphingosine 1-Phosphate Receptor 1 Sales by Region (2027-2032)
  5. 6.3 Global Sphingosine 1-Phosphate Receptor 1 Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Sphingosine 1-Phosphate Receptor 1 Sales Value by Region (2021-2032)
  7. 6.4.1 Global Sphingosine 1-Phosphate Receptor 1 Sales Value by Region: 2021-2026
  8. 6.4.2 Global Sphingosine 1-Phosphate Receptor 1 Sales Value by Region (2027-2032)
  9. 6.5 Global Sphingosine 1-Phosphate Receptor 1 Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Sphingosine 1-Phosphate Receptor 1 Sales Value (2021-2032)
  12. 6.6.2 North America Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Sphingosine 1-Phosphate Receptor 1 Sales Value (2021-2032)
  15. 6.7.2 Europe Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Sphingosine 1-Phosphate Receptor 1 Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Sphingosine 1-Phosphate Receptor 1 Sales Value (2021-2032)
  21. 6.9.2 South America Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Sphingosine 1-Phosphate Receptor 1 Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Country, 2025 VS 2032
7 Sphingosine 1-Phosphate Receptor 1 Country-level Sales and Value Analysis
  1. 7.1 Global Sphingosine 1-Phosphate Receptor 1 Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Sphingosine 1-Phosphate Receptor 1 Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Sphingosine 1-Phosphate Receptor 1 Sales by Country (2021-2032)
  4. 7.3.1 Global Sphingosine 1-Phosphate Receptor 1 Sales by Country (2021-2026)
  5. 7.3.2 Global Sphingosine 1-Phosphate Receptor 1 Sales by Country (2027-2032)
  6. 7.4 Global Sphingosine 1-Phosphate Receptor 1 Sales Value by Country (2021-2032)
  7. 7.4.1 Global Sphingosine 1-Phosphate Receptor 1 Sales Value by Country (2021-2026)
  8. 7.4.2 Global Sphingosine 1-Phosphate Receptor 1 Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Sphingosine 1-Phosphate Receptor 1 Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Sphingosine 1-Phosphate Receptor 1 Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Sphingosine 1-Phosphate Receptor 1 Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Sphingosine 1-Phosphate Receptor 1 Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Sphingosine 1-Phosphate Receptor 1 Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Sphingosine 1-Phosphate Receptor 1 Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Sphingosine 1-Phosphate Receptor 1 Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Sphingosine 1-Phosphate Receptor 1 Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Sphingosine 1-Phosphate Receptor 1 Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Sphingosine 1-Phosphate Receptor 1 Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Sphingosine 1-Phosphate Receptor 1 Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Sphingosine 1-Phosphate Receptor 1 Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Sphingosine 1-Phosphate Receptor 1 Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Sphingosine 1-Phosphate Receptor 1 Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Sphingosine 1-Phosphate Receptor 1 Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Sphingosine 1-Phosphate Receptor 1 Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Sphingosine 1-Phosphate Receptor 1 Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Sphingosine 1-Phosphate Receptor 1 Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Sphingosine 1-Phosphate Receptor 1 Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Sphingosine 1-Phosphate Receptor 1 Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Sphingosine 1-Phosphate Receptor 1 Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Sphingosine 1-Phosphate Receptor 1 Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Sphingosine 1-Phosphate Receptor 1 Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Sphingosine 1-Phosphate Receptor 1 Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Sphingosine 1-Phosphate Receptor 1 Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Sphingosine 1-Phosphate Receptor 1 Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Sphingosine 1-Phosphate Receptor 1 Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Sphingosine 1-Phosphate Receptor 1 Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Sphingosine 1-Phosphate Receptor 1 Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Novartis AG
  2. 8.1.1 Novartis AG Company Information
  3. 8.1.2 Novartis AG Business Overview
  4. 8.1.3 Novartis AG Sphingosine 1-Phosphate Receptor 1 Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Novartis AG Sphingosine 1-Phosphate Receptor 1 Product Portfolio
  6. 8.1.5 Novartis AG Recent Developments
  7. 8.2 Bristol-Myers Squibb Company
  8. 8.2.1 Bristol-Myers Squibb Company Company Information
  9. 8.2.2 Bristol-Myers Squibb Company Business Overview
  10. 8.2.3 Bristol-Myers Squibb Company Sphingosine 1-Phosphate Receptor 1 Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Bristol-Myers Squibb Company Sphingosine 1-Phosphate Receptor 1 Product Portfolio
  12. 8.2.5 Bristol-Myers Squibb Company Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Sphingosine 1-Phosphate Receptor 1 Value Chain Analysis
  2. 9.1.1 Sphingosine 1-Phosphate Receptor 1 Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Sphingosine 1-Phosphate Receptor 1 Sales Mode & Process
  6. 9.2 Sphingosine 1-Phosphate Receptor 1 Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Sphingosine 1-Phosphate Receptor 1 Distributors
  9. 9.2.3 Sphingosine 1-Phosphate Receptor 1 Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst